Jim DeNike

Investor Relations Contact at MBX BIOSCIENCES, INC.

Health Technology

Profile

Jim DeNike currently works at MBX Biosciences, Inc., as Investor Relations Contact.
Mr. DeNike also formerly worked at Emergent Product Development Seattle, as Senior Director-Corporate Communications, NS Wind Down Co., Inc., as Senior Director-Corporate Communications & IR, Marinus Pharmaceuticals, Inc., as Senior Director-Investor Relations from 2023 to 2024, OncoGenex Pharmaceuticals, Inc., as Investor Relations Contact, and Acer Therapeutics, Inc., as Investor Relation Contact.

Jim DeNike active positions

Companies	Position	Start
MBX BIOSCIENCES, INC.	Investor Relations Contact	-

All active positions of Jim DeNike

Former positions of Jim DeNike

Companies	Position	End
MARINUS PHARMACEUTICALS, INC.	Investor Relations Contact	01/05/2024
ACER THERAPEUTICS INC.	Investor Relations Contact	01/08/2023
NS WIND DOWN CO., INC.	Public Communications Contact	01/11/2014
OncoGenex Pharmaceuticals, Inc. OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients	Investor Relations Contact	-
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products	Public Communications Contact	-

See the detail of Jim DeNike's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jim DeNike's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products	Health Technology
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders	Health Technology
NS Wind Down Co., Inc. NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products	Health Technology
OncoGenex Pharmaceuticals, Inc. OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients	Health Technology
Acer Therapeutics, Inc. Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases	Health Technology
MBX Biosciences, Inc. MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders	Health Technology

See company connections